Explore our Microsites

Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.

Blog

Dec 10, 2015

Biologics and Biosimilars Bits and Bytes - December 10, 2015

Amgen files for first European Approval of a Biosimilar to Humira® On December 4, 2015, Amgen Inc. (Amgen) announced the filing of a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for ABP 501, a biosimilar version of AbbVie Inc.'s (AbbVie) Humira® (adalimumab). According to Amgen, its MAA submission included analytical, clinical and […]
back to top